External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma.

Jung-Yun LeeYoung Shin ChungKiyong NaHye Min KimCheol Keun Park Eun Ji Nam Sunghoon Kim Sang-Wun KimYoung Tae KimHyun Soo Kim

Published in: Journal of gynecologic oncology (2017)

The CRS system for assessing NAC response was a reproducible prognostic tool in our cohort. The application of the CRS system after NAC can improve survival estimation in HGSC patients.

Keyphrases

high grade
neoadjuvant chemotherapy
locally advanced
end stage renal disease
transcription factor
low grade
ejection fraction
chronic kidney disease
newly diagnosed
lymph node
peritoneal dialysis
sentinel lymph node
rectal cancer
squamous cell carcinoma
prognostic factors
radiation therapy
genome wide analysis